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Resumo 
Esta dissertação teve como objetivo o desenvolvimento de espumas porosas de hidroxiapatite 
(HA) baseadas em réplicas invertidas de cristais coloidais (ICC) para substituição óssea. Um 
ICC é uma estrutura tridimensional de elevada porosidade que apresenta uma rede 
interconectada de poros com elevada uniformidade de tamanhos. Este tipo de arquitetura 
possibilita uma proliferação celular homogénea e superiores propriedades mecânicas quando 
comparada com espumas de geometria não uniforme. 
O cristal coloidal (CC) - o molde da espuma - foi criado por empacotamento de microesferas de 
poliestireno (270 μm) produzidas por microfluídica e posterior tratamento térmico.  
O molde foi impregnado com um gel de hidroxiapatite produzido via sol-gel utilizando pentóxido 
de fósforo e nitrato de cálcio tetrahidratado como percursores de fósforo e cálcio, 
respectivamente. A espuma cerâmica foi obtida num único passo depois de um tratamento 
térmico a 1100
o
C que permitiu a solidificação do gel e a remoção do CC.  
A análise por espetroscopia de infravermelho por transformada de Fourier (FTIR) e difração de 
raios-X (XRD) revelou uma hidroxiapatite carbonatada tipo A com presença de fosfatos 
tricálcicos. As propriedades mecânicas foram avaliadas por testes de compressão. A 
biocompatibilidade in vitro foi demonstrada através de testes de adesão e proliferação celular 
de osteoblastos. 
 
 
 
Palavras-Chave: réplicas invertidas de cristais coloidais, hidroxiapatite, substituto ósseo, 
microfluídica. 
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Abstract 
This dissertation focuses on the production of hydroxyapatite (HA) inverse colloidal crystal (ICC) 
scaffolds for bone tissue engineering. An inverse colloidal crystal is a three dimensional porous 
structure that has highly uniform pore sizes and a fully interconnected pore network with high 
porosity. This kind of architecture provides a homogeneous cell proliferation and better 
mechanical properties when compared with the available scaffolds with non-uniform geometry.  
The colloidal crystal (CC) - the scaffold template - was created by self-assembly and 
subsequent annealing of polystyrene microspheres (270 μm) produced through a microfluidics 
based technique. 
In order to fabricate the ceramic ICC scaffold, the template was impregnated with a 
hydroxyapatite gel produced by a sol-gel route. Phosphorus pentoxide and calcium nitrate 
tetrahydrate were used as sol precursors of phosphorus and calcium, respectively. The 3D final 
structure was obtained in a single step after thermal treatment at 1100
o
C, allowing gel 
transformation into a solid HA block and CC removal. 
Scaffold analysis by Fourier-Transform Infrared Spectroscopy (FTIR) and X-ray diffraction 
(XRD) revealed a type A carbonated hydroxyapatite with traces of β-tricalcium phosphate. 
Mechanical properties were evaluated by compression tests. In vitro biocompatibility was 
demonstrated through cell adhesion and proliferation tests after human osteoblast cell seeding 
in the scaffolds. 
 
 
 
Keywords: Inverse colloidal crystals, hydroxyapatite, bone substitute, microfluidics. 
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1. Background 
The aim of this dissertation was the development of a hydroxyapatite porous scaffold for bone 
tissue engineering with an inverted colloidal crystal (ICC) architecture. 
Hydroxyapatite has been used as scaffolding material for bone substitution. It has a chemical 
composition that resembles the mineral phase of human bone and consequently, an 
outstanding biocompatibility.  
When designing a scaffold it would be desirable to reproduce bone’s properties in terms of 
composition and internal morphology as it should be able to support cell growth. It has been 
known that cells behavior is strongly affected by the scaffold properties, particularly by the 
constituent material’s nature, its pores interconnectivity, uniformity and size distribution.  
Many types of hydroxyapatite scaffolds have been developed throughout the years but most of 
the fabrication techniques result in structures with random pore distributions. Consequently, the 
interconnectivity between pores is insufficient. This feature directly affects the nutrients, 
metabolites diffusion and bone regeneration. Although an increase in porosity degree could 
solve this problem, the scaffold’s mechanical strength would be compromised in a way that it 
wouldn’t be able to maintain structural stability until complete regeneration of the damaged bone 
tissue. Additionally, a random arrangement of pores doesn’t allow a good scaffold-to-scaffold 
reproducibility. 
Inverted colloidal crystals emerged as a new type of three-dimensional scaffolds with controlled 
pore sizes, interconnectivity between pores and an ordered and uniform structure. The ability to 
control the architecture features allows obtaining scaffolds with better mechanical properties, 
which is important when designing an implant for a structural tissue like bone. 
Combining such features with a bioactive material like hydroxyapatite may also enable an 
optimization of the scaffold‘s biological performance. 
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2. Introduction 
2.1. Hydroxyapatite 
Hydroxyapatite (HA) is a bioceramic that belongs to the apatite group and has the chemical 
formula Ca10(PO4)6(OH)2, with a Ca:P molar ratio of 1.67 [1].  
Synthetic hydroxyapatite can be chemically obtained with outstanding similarity to biological 
apatites, which comprise the mineral phases of calcified tissues in the human body such as 
bone, dentin and enamel. The biological HA is usually calcium-deficient (Ca:P < 1.67) and is 
able to suffer a wide variety of substitutions in regular HA lattice points that may involve ions of 
Mg
2+
, Na
+
, K
+
, Sr
2+
, or Ba
2+
 for Ca
2+
,  CO3
2 -
,  H
2
PO
4
 -
,  HPO4
2 -
 and  SO4
2 -
  for  PO4
3 -
, and F-, Cl- and  
CO3
2 -
 for OH- [2], [3]. 
Synthetic hydroxyapatite based ceramics have shown to be suitable for biomedical applications, 
such as bone repair, augmentation and substitution [4], [5]. They exhibit excellent 
biocompatibility with both hard and soft tissues, such as skin and muscle, as a result of similarity 
with bone’s inorganic phase. Moreover, HA is bioactive, and promotes osseointegration when 
directly implanted into bone [5], [6]. 
Despite these excellent features, this bioceramic shows limited mechanical properties, which 
are dependent on grain size and on the presence of impurities, whose influence is determinant 
when a highly porous sample is considered. 
The biological behavior of HA ceramics depends on many factors, in particular, on their 
chemical and phase composition, microstructure, pore size, and porosity [7]. 
2.1.1. Porosity of HA ceramics 
When developing  porous HA for bone replacement, a special feature has to be addressed, like 
mimicking the macro and microporous architecture of bone, which consists of 55% - 70% 
interconnected porosity [3]. 
Porous HA allows a strong bonding to bone being the pores the providers of mechanical 
interlock leading to a firm material fixation. Bone tissue penetrates and grows into the pores, 
increasing strength of the HA implant [8], [9]. Also, pores dimension and morphology are crucial 
factors for an excellent osseointegraton. A minimum size of 100 m required to enable bone 
ingrowth into implants [10]. Many research groups have reported the optimum pore sizes for 
various kinds of cells or tissues: for example, 5–15 m for fibroblasts; ≈ 20 m for hepatocytes; 
70–120 m for chondrocytes; 40–150 m for fibroblast binding; 60–150 m for vascular smooth 
muscle cell binding; 100–300 mm for bladder smooth muscle cell adhesion and ingrowth; 100–
400 m for bone regeneration, and 200–350 m for osteoconduction [11]. 
An essential requirement for porous implants is pores interconnectivity, which is essential to 
circulation and exchange of body fluids, ion diffusion, nutritional supply and osteoblast cell 
 
4 
 
 
penetration. In this context, closed pores do not participate in physiological events due to lack of 
accessibility by body fluids and cells. Other important requirement is implant surface roughness 
for cells attachment [8].  
In summary, porosity, pore-size distribution, pore morphology and orientation, as well as the 
degree of pore interconnectivity strongly affect implant-tissue osseointegration.  
2.2. Hydroxyapatite scaffolds: production methods and commercial availability  
Various scaffold fabrication techniques have been developed in order to reproduce the structure 
and dynamics of bone tissue. The geometry of these scaffolds mainly depends on the process, 
and usually a poorly ordered structure is obtained with some closed porosity. Consequently, 
porosities often approach 95% to ensure a complete interconnectivity throughout the scaffold. 
Such high level of porosity present a dilemma in bone tissue engineering since it enhances 
interconnectivity but denies the scaffold of sufficient mechanical strength to ensure structural 
support until tissue regeneration is complete [12]. This issue becomes even more complex 
when considering brittle materials, such as hydroxyapatite. 
A summary of advantages and disadvantages of some of the available methods to produce HA 
porous scaffolds is presented in table 2.1. For each technique, there is a wide range of possible 
features for the resultant scaffold, depending on the experimental conditions applied.  
To overcome the randomness in the structures obtained by the majority of these techniques 
(example, Figure 2.1), methods like solid freeform fabrication have been developed. This kind of 
approach enables the production of 3D porous molds with desired properties such as porosity, 
interconnectivity and architecture. A hydroxyapatite positive replica of this mold can be therefore 
produced (Figure 2.2). 
 
 
 
 
 
 
 
 
 
Although very promising, this method still carries some disadvantages (Table 2.1). As a solution 
for the limitations related to the proposed methods of HA scaffolds production, several studies 
have mentioned a well-defined scaffold with an high degree of interconnectivity called Inverse 
Colloidal Crystal (ICC) [11], [13], [14]. 
A B 
Figure 2.1 - (A) Section and (B) surface of 
porous HA scaffold produced by polymer 
replication method [15]. 
Figure 2.2 - (A) Resin mold produced by 
stereolithography and resulting (B) HA scaffold 
with controlled internal architecture [15]. 
A B 
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There are already some commercially available HA porous scaffolds for bone tissue 
replacement (Table 2.2). 
 
Table 2.1 - Available methods to produce porous hydroxyapatite scaffolds. 
 
 
Table 2.2 - Commercially available HA scaffolds for bone tissue replacement. 
Method % Porosity Advantages Disadvantages Ref. 
Polymer 
replication 
25 - 90 
Complex shapes; high degree 
of interconnected porosity 
Pore size distribution is not 
easily controllable; poor 
mechanical strength for load-
bearing applications 
[15]–[18] 
Gel casting of 
foams 
70 - 90 
High mechanical strength; 
complex shapes 
Poorly interconnected pores; 
non-uniform pore size 
distribution 
[19], [20] 
Starch 
consolidation 
45 - 70 
Simplicity of the process; 
possibility of using various 
mold materials to produce 
complex shapes; low-cost 
processing 
equipment/materials needed 
Low mechanical strengths for 
high pore volume fractions and 
vice-versa 
[21] 
Microwave 
processing 
73 High porosities Small pore sizes [22] 
Slip casting > 50 
Large pore sizes;  controllable 
pore size distribution; complex 
shapes 
Slow process; poor control over 
internal architecture [23] 
Electrophoretic 
deposition 
20 
Uniform and crack-free bulk 
porous scaffolds; 
interconnected porosity good 
mechanical strength; no 
additives/binders needed 
Wide range of pore sizes; high 
cost for large components; Low 
porosity 
[24] 
Cold isostatic 
pressing 70 
Spherical porosity 
Incomplete interconnectivity 
between pores [25] 
Freeze casting 40 - 65 
Complex shapes; precise 
control over pore properties; 
directional porosity; 
high compressive strength 
Pore sizes usually small [26], [27] 
Dual-phase 
mixing 
50 - 70 High mechanical strength 
Incomplete interconnectivity 
between pores; non-uniform 
pore size distribution 
[28] 
Solid freeform 
fabrication 
– 
Complex shapes and 
architectures; 
uniform and controllable pore 
sizes 
Time-consuming; computer-
aided design; complex 
equipment; inadequate 
resolution (for small sizes) 
[15], [29] 
Company - Product 
Composition 
(% HA - % β-TCP) 
Porosity 
(%) 
Pore size 
(m) 
Compressive 
strength (MPa) 
Ref. 
Ceramed - NeoBone
®
 75 - 25 60 - 80 200 - 500 > 0.2 [30], [31] 
Ceramisys - ReproBone™ 60 - 40 83 200 - 800 > 1.5 [32], [33] 
Graftys - Graftys
®
BCP 60 - 40 70 > 100 > 10 [34] 
Kasios - TCH
®
 75 - 25 60 - 80 200 - 500 > 5 [35] 
Ldr - BF+
®
 60 - 40 60 - 80 200 - 500 N.A. [36] 
Medbone - adbone
®
BCP 75 - 25 80 300 - 500 1 - 2 [37] 
Teknimed - Ceraform
®
 65 - 35 60 - 85 150 - 400 N.A. [38] 
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2.3. Inverse Colloidal Crystals 
An inverse colloidal crystal (ICC) is a three dimensional porous structure that has highly uniform 
pore sizes and a fully interconnected pore network with high porosity. 
These properties enhance cell migration efficiency, diffusion of nutrients and metabolites, and a 
rapid and uniform distribution of soluble signaling molecules. A superior performance of the 
ICC’s has been confirmed when in comparison to scaffolds with non-uniform pores and 
structures [13]. 
From a manufacturing standpoint, the fabrication procedure of ICC scaffolds is simple, flexible 
and allows a great reproducibility among different batches (which is not always possible when 
using other scaffold production methods such as, polymer replication or gel casting). 
 
 
 
 
 
 
 
 
First, microspheres with uniform size are assembled into an ordered structure; they tend to 
organize themselves (self-assembly) into thermodynamically stable forms, face-centered cubic 
(fcc) and hexagonal close-packed (hcp) structures (Figure 2.3 - A) [14]. The resulting structure 
is called colloidal crystal (CC). 
In order to create a solid object, the microspheres are subjected to thermal annealing to induce 
necking between adjacent microspheres [39]. The major factor that influences this process is 
the crystallinity of the polymer used to produce the microspheres. Amorphous polymers, like 
polystyrene (PS), that soften above its glass transition temperature enable an easier production 
of the bridges between the microspheres allowing an easier production of the solid construct. 
This treatment is also responsible for the diameter of the interconnected pores. With the 
increase of the annealing temperature, the bridges between consecutive spheres increase as 
well, resulting in ICC scaffolds with interconnected pores with windows of higher diameters [40]. 
Then, a solution containing the scaffolding material is infiltrated into the lattice (Figure 2.3 - B). 
Any precursor solution capable of undergoing a liquid-to-solid transition may potentially be used 
as a scaffolding material. According to its properties, the material must be subjected to a 
specific treatment in order to promote solidification.  
Figure 2.3 - ICC fabrication process: (A) Microspheres self-assembled in a hcp structure;              
(B) Microspheres infiltrated with scaffolding material; (C) Microspheres template removal (Adapted  
from [39]). 
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Lastly, the lattice is selectively removed, leaving behind an inverse opal scaffold with uniform 
pore sizes and a long-range ordered structure defined by the microspheres solid structure 
(Figure 2.3 - C). Thanks to hcp geometry created by the microspheres self-assembly, each 
spherical cavity is connected with up to 12 nearest-neighbour cavities with two types of pores in 
different sizes. This type of geometry guarantees a maximum theoretical porosity of 74% [12]. 
Some scaffolds based on ICC structures aiming bone tissue repairing have already been 
reported. Cuddihy and Kotov [12] produced biodegradable poly(lactic-co-glycolic acid) (PLGA) 
ICC scaffolds through a soda lime microspheres template. This scaffolds demonstrated high 
mechanical properties (>50 MPa) and in vitro biocompatibility. Their studies indicated trends 
that larger pore sizes (100 – 330 μm) may increase cell and bone growth.  
Nichols et al. [41] reported the development of an in vitro artificial bone marrow based on a 
scaffold with inverted colloidal crystal geometry mimicking the structural topology of actual bone 
marrow matrix. Scaffolds were manufactured composed of either silicate or hydrogel using a 
polystyrene colloidal crystal which produced cavities of 110 μm connected by 10 – 20 μm 
channels. The system allowed the growth and differentiation of cells. 
Choi et al. [11] presented a technique for fabricating chitosan ICC’s in an array of 
poly(caprolactone) (PCL) microspheres of 147.7 m in average diameter. It resulted in 
structures with a nanofibrous texture on the walls surface promoting bone cells adhesion and 
proliferation. The tensile strength of the scaffolds was in the range of 30 to 60 kPa. 
Takagi et al. [40] developed 𝛽-tricalcium phosphate (𝛽-TCP) ICC scaffolds by ceramic slip 
casting using polyethylene microspheres (ranging from 300 to 600 μm) assembled into an fcc 
lattice. The fabricated scaffolds showed an ordered pore structure with uniformly sized 
macropores and pore interconnection pathways that faithfully replicated the particles and their 
necks in the template, respectively. 
With the purpose of recreating bone’s constitution (an organic and a mineral phase), a 
composite structure was produced: Choi, Zhang and their collaborators [42] presented ICC’s 
made of PLGA and HA using lattices of uniform gelatin microspheres as templates. Three 
formulations were examined: pure PLGA, PLGA/HA and apatite-coated PLGA/HA. With an 
average pore size of 213 μm, the scaffolds exhibited different compressive modulus: 196.2 kPa 
for the PLGA scaffolds, 1744.7 kPa for the PLGA/HA scaffolds, 1952.8 kPa for apatite-coated 
PLGA/HA scaffolds. 
In this work the production of hydroxyapatite scaffolds with ICC geometry for bone tissue 
engineering will be explored. 
 
  
 
8 
 
 
  
 
 
9 
 
3. Materials and Methods 
3.1. Hydroxyapatite Production 
Hydroxyapatite was produced using a sol-gel route. The experimental procedure was based on 
the works reported by Feng et al. [43] and Franco et al. [44]. Solutions containing calcium and 
phosphorous precursors in ethanol were mixed together in a Ca/P molar ratio of 1.67. A 
translucent gel with low viscosity was obtained after stirring this mixture for 5h and aging it for 
24h, both at ambient temperature. 
Posteriorly, the obtained HA gel was mixed with binders (a 25 wt.% poly(vinyl acetate) (PVAc) 
solution in acetone or a 25 wt.% polyvinylpyrrolidone (PVP) solution in ethanol) in a 98:2 weight 
ratio.  
Reagents: 
 Absolute Ethanol: C2H6O, Fisher Scientific; 
 Acetone: C3H5O, Fisher Scientific; 
 Calcium Nitrate 4-hydrate: Ca(NO3)2.4H2O, Panreac; 
 Phosphorous Pentoxide: P2O5, Sigma-Aldrich; 
 Poly(vinyl acetate): (C4H6O2)n, Acros Organics, Mw ~ 100,000; 
 Polyvinylpyrrolidone: (C6H9NO)n, Sigma-Aldrich, Mw ~ 1,300,000. 
 
3.2. Inverse Colloidal Crystal Fabrication 
3.2.1. Microspheres Production 
Uniform polystyrene spheres with average diameters 
of (270 ± 8) μm were produced using a microfluidic 
device as described in [45] (Figure 3.1).  
Based on this technique, a 5 wt.% PS solution in 
dichloromethane contained on a syringe with a 25G 
needle was used as the discontinuous phase (DP). 
For the continuous phase (CP) an aqueous solution 
of 5 wt.% poly(vinyl alcohol) (PVA)  contained on a 
syringe with a 18G needle was used. 
The continuous phase polymer was chosen mainly 
due to its hydrophilic properties. Its combination with 
the hydrophobic PS phase enables the formation of 
an emulsion droplet. 
The flow rates for the discontinuous and continuous 
phases were held at 3 and 20 mL/h, respectively.  
Figure 3.1 - Microfluidic device used for 
microsphere production. A - continuous          
phase; B - discontinuous phase [46]. 
A 
 
B 
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The resulting microspheres were set in orbital agitation until solvent evaporation. Afterwards, 
they were washed with distilled water and size separated with appropriated sieves.  
Reagents: 
 Dichloromethane: CH2Cl2, PA Fisher; 
 Polystyrene: [CH2CH(C6H5)]n, Aldrich, Mw ~ 350,000;  
 Poly(vinyl alcohol) : [-CH2CH(OH)-]n, Acros Organics, 95% hydrolyzed. 
 
3.2.2. Colloidal Crystal Template Fabrication 
The colloidal crystal template was created by self-assembly of the PS microspheres (into an hcp 
structure) in a cylindrical mold (Figure 3.2) under orbital agitation. Subsequently, the 
microspheres were heated at 130
o
C for 4 hours to promote annealing between adjacent 
microspheres. A solid structure was obtained after mold removal.  
 
Figure 3.2 - Colloidal crystal mold with 32 cavities with 5,93 mm of diameter [46]. 
 
3.2.3. Hydroxyapatite Inverse Colloidal Crystal Fabrication 
The obtained CC was infiltrated with the HA + binder gel mixture (§ 3.1), by introducing the 
sample into this solution and then promoting its penetration under vacuum. After being removed 
from solution, excess gel was cleaned from CC’s exterior walls. 
The impregnated template was placed in a muffle oven (Select-Horn Electric Muffle Furnace) 
and held at 75ºC for 20h. The temperature was then increased to 450ºC at a rate of 2ºC/min 
and held for 2h. The previous heating rate was maintained followed by a 2h level at 550ºC. 
Lastly the structure was put at 1100ºC for 2h to sinterize, with a heating rate of 10ºC/min.  
 
3.3. Characterization 
3.3.1. Optical Microscopy 
Microspheres diameters were measured with an optical microscope (Olympus Microscope 
Digital Camera DP73). This measurement was performed in 100 random samples of each 
production lot. 
 
 
 
11 
 
(1) t = 
0.9 𝜆
𝛽 cos θB
,   [𝑛𝑚] 
(2) 
3.3.2. TG-DSC 
Glass transition and fusion temperatures of PS, PVP and PVAc were evaluated by differential 
scanning calorimetry (DSC) and thermogravimetry (TG). This step had the purpose of 
evaluating the materials thermal compatibility to optimize the annealing temperature, sintering 
and degradation steps.  
 
3.3.3. XRD 
The phase composition and crystallinity of HA was analyzed by X-ray diffraction (XRD) using 
CuKα radiation generated at 45 kV and 40 mA, in the range of 20°<2θ<60°, in a X’Pert PRO 
(PANAlytical) X-ray diffractometer. The obtained peaks were compared with JCPDS cards: #09-
0169, #09-0348, #09-0432, e #37-1497. Crystallite sizes (t) were calculated from X-ray 
diffraction patterns using the Scherrer formula [47]: 
 
 
 
 
 
𝜆 – X-ray wavelength; 𝛽 – full width at half maximum of diffraction peak; θB – Bragg angle. 
The crystallinity degree (𝑋𝑐), corresponding to the fraction of crystalline phase present in the 
examined samples was evaluated by the following equation [48]: 
 
 
 
𝐼300 – intensity of (300) diffraction peak;  𝑉112 300⁄  – intensity of the hollow between (112) and 
(300) diffraction peaks of hydroxyapatite.  
 
3.3.4. FTIR 
Fourier-Transform Infrared Spectroscopy (FTIR) analysis was carried out to identify the 
functional groups of HA. A Thermo Scientific (model Nicolet 6700) spectrometer was used. 
 
3.3.5. SEM 
Morphological observations of PS CC’s and HA ICC’s were performed in a Zeiss (model DSM 
962) scanning electron microscope (SEM). All samples were sputter-coated with gold before 
SEM observation. 
 
3.3.6. Mechanical tests: Compression  
Uniaxial mechanical properties of ICC’s were determined using a Rheometric Scientific (Minimat 
Firmware 3.1) with a 20 N load cell at a rate of 0.5 mm/min. 
 
𝑋𝑐 = 1 −
𝑉112 300⁄
𝐼300
× 100,   [%] 
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3.3.7. Cell Adhesion and Proliferation Tests 
Biocompatibility of HA ICC’s was evaluated through cell adhesion and proliferation studies. In 
this work human osteoblasts from Saos-2 cellular line and a solution of McCoy’s 5A Medium 
(Sigma-Aldrich) supplemented with 10% of Fetal Bovine Serum (Gibco®) and 1% of Penicillin-
Streptomycin (Gibco®) as cell culture medium were used. The chosen cells were seeded direct 
over with the material surface. The ICC’s used in the study were sterilized as described in 
Appendix A.1.  
Firstly, the osteoblasts were thawed (Appendix A.2) and its subculture was prepared (Appendix 
A.3).  
The ICC’s were placed in a multi well plate. Four different “types of wells” were prepared:  
 Medium Control well: containing medium without cells; 
 ICC Medium Control well: containing ICC’s and medium without cells; 
 Cell Control well: containing medium with cells; 
 Test well: containing ICC’s and medium with cells.  
Cells were seeded in the last two types of wells at a concentration of 30 000 cells/well. 
After 20h of incubation at 37
o
C (Sanyo CO2 incubator), the culture medium was removed from 
the wells and in its place was added a solution of resazurin (0.2 mg/mL) and culture medium 
(10% V/V). After 2h of incubation the solution contained in the wells was transferred to a well 
microplate. 
The fluid absorbance was measured at 570 and 600 nm in a microplate reader (Biotek ELx 
800). The cells were cultured for 10 days. Absorbance readings were performed at days 1, 3, 6, 
8 and 10 following the procedure described in the previous paragraph. 
This step provides the necessary data to estimate cell adhesion and evaluate proliferation. 
Viable cells with active metabolism can reduce resazurin into the resorufin product which is pink 
and fluorescent and thus it changes the solution’s color. This color change can be detected 
using absorbance measurements. The corrected absorbance is proportional to the number of 
living cells and corresponds to the cells metabolic activity. Damaged and nonviable cells have 
lower metabolic activity and thus generate less resorufin than healthy cells. A more detailed 
protocol is described in Appendix A.4. 
After the 10 days the cells were fixed with paraformaldehyde (PFA) to the ICC samples. The 
fixed cells were stained with DAPI (4',6-diamidino-2-phenylindole) so it was possible to observe 
them using fluorescence microscopy (Appendix A.5).   
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4. Results and Discussion 
4.1. CC fabrication 
4.1.1. Polystyrene Microspheres 
4.1.1.1. Tuning of microspheres diameter 
The diameter of the produced microspheres can be tuned mainly by changing the flow rate of 
each phase or the polymer concentration of the discontinuous phase. In this work, the DP 
corresponds to a polystyrene solution and the CP corresponds to a PVA solution (§ 3.2.1). 
As previously mentioned, it is required a minimum scaffold pore size of 100 m to enable bone 
ingrowth. It is also known that osteoblasts are about 10-30 m in size. Usually, the ICC’s 
windows diameter corresponds to about a third or quarter of the pores diameter (depending on 
the annealing conditions), so, in order to avoid windows blockage by cells and enable cell 
diffusion throughout the scaffold these facts should be taken into consideration. 
Therefore, the effects of polymer concentration and flow rate were studied to try to achieve a 
microsphere diameter in the range of 200-300 m. Joana Vasconcelos work [46] was followed 
for some guidelines regarding flow rates and solutions concentration values. The effect of the 
flow rate on the average diameter was explored by holding the flow rate of the DP constant and 
varying the CP flow rate.  
The following table contains all the variations imposed to CP flow rate, as well as the resultant 
microspheres diameter.  
Table 4.1 - Influence of continuous phase flow rate on microspheres diameter. 
DP concentration 
(wt. %) 
DP flow rate 
(mL/h) 
CP concentration 
(wt. %) 
CP flow rate 
(mL/h) 
Diameter 
(m) 
Error 
(m) 
5 20 5 
10 317 15 
20 270 8 
30 222 9 
40 187 8 
As expressed by Choi et al. [45] an increase in flow rate for the CP resulted in a reduction in 
microsphere diameter due to the increase in the shear stress imposed on the DP droplet (Figure 
4.1). 
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Figure 4.1 - Influence of CP flow rate on microspheres diameter (CP concentration: 5 wt. %; DP 
concentration: 5 wt. %; DP flow rate: 3 mL/h). 
 
The chosen flow rates were: 20 ml/h for the continuous phase (PVA) and 3 mL/h for the 
discontinuous phase (PS). This conjugation generated microspheres with an average diameter 
of (270 ± 8) μm. 
The resultant PS microspheres presented a negligible amount of defects, a uniform size 
distribution and spherical symmetry.  
4.1.1.2. Effect of temperature on Polystyrene 
Since the PS microspheres had to be subjected to several thermal conditions - the CC’s 
annealing and degradation during ICC’s production - it was necessary to analyze this polymer 
thermal behavior. A TG-DSC analysis was used to obtain the required data. The corresponding 
thermogram is shown in Figure 4.2. 
Being an amorphous polymer, it doesn’t have a specific melting point; instead, it softens 
gradually as the temperature rises from the glass transition temperature, 𝑇𝑔 - above this 
temperature, there’s an increased freedom of movement of local "segments" within the polymer 
chain. The 𝑇𝑔 was observed at 97.2ºC (it corresponds to the first peak midpoint temperature in 
the thermogram). 
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Figure 4.2 - TG-DSC thermogram for polystyrene with amplification of the area corresponding to 
the 𝑻𝒈 peak. 
 
At about 307ºC the PS starts to degrade (there is a significant mass loss as seen in the figure 
above). The degradation is complete past the last endothermic peak, which corresponds to the 
degradation temperature. At this point, individual bonds between atoms start to break as the 
vibrations become more and more fierce until eventually, individual polymer molecules 
decompose into their components.  
Based on the results, the annealing of the CC template should be done between 97.2ºC and 
307ºC, knowing that higher annealing temperatures can cause a wider spread of the 
microspheres template material.  
Also, in the ICC production process, the temperature must exceed the PS degradation 
temperature in order to create a porous structure by elimination of the polymer. 
4.1.2. Effects of time and annealing temperature on CC template 
Considering that PS begins to soften after approximately 97.2
o
C, a range of annealing 
temperatures (110-140
o
C) was selected to produce cohesive CC’s with complete 
interconnectivity between adjacent microspheres.  
The upper limit of the temperature range was chosen so that microspheres were not 
excessively melted, which would inhibit the HA gel infiltration in the spaces between 
microspheres. Also, it could result in ICC’s with non-spherical porosity and excessive windows 
diameters. These facts would compromise the final product stability. 
 
16 
 
 
Below 125
o
C, the edges of CC’s crumbled when removed from the mold; at lower temperatures 
the annealing was insufficient to provide enough structural integrity for handling. Thereby, 
higher temperatures were explored. 
The temperature that allowed the production of CC’s with the best characteristics was 130
o
C. 
Annealing time also affects the CC’s features. It is known that for the same annealing 
temperature, a longer thermal treatment will result in ICC’s with wider windows. Therefore, a 
compromise between time and temperature was made.  
The annealing time was varied between 4 and 5.30h for the temperatures mentioned above.  
The chosen time for CC´s production was 4h for an annealing temperature of 130
o
C, resulting in 
cohesive CC’s with interconnected microspheres and enough open spaces for ICC’s material 
infiltration (Figure 4.3).  
Some irregularities were observed in the CC template as a result of dispersion of microspheres 
diameter which resulted in uneven necking in some scaffold areas.  
 
Figure 4.3 - SEM image of colloidal crystal produced at 130
o
C. 
 
4.2. Hydroxyapatite Gel 
4.2.1. Agitation Time 
The agitation time of HA sol was varied to obtain a gel with adequate viscosity capable of being 
effectively impregnated into the CC’s.  
A gel with high viscosity wouldn’t allow its efficient infiltration into the colloidal crystal, leaving 
gaps along the structure without any material. On the other hand, a gel with high fluidity would 
flow through the microspheres template resulting in a structure with insufficient material on the 
walls. Both conditions would result in fragile and unstable ICC’s.  
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A balance between these opposite extremes was found by varying the agitation time of HA sol 
until a gel with low viscosity was obtained. The attempted agitation times varied from 4 to 24 
hours at 60 rpm (ambient temperature).  
The viscosity of the resulting gel increased with agitation time becoming whiter each time. The 
sol agitation promotes the formation of a three dimensional network by aggregation of separate 
particles (transformation into a gel phase - gelation) and therefore the solution viscosity rises. 
However, the continuous stirring begins, at one point, to break this network apart. Accordingly, it 
can be said that the extended gel agitation slows or inhibits the complete gelation. 
The gel with the most suitable viscosity was achieved after stirring for about 5 hours at ambient 
temperature (Figure 4.4).  
4.2.2. Aging time 
As part of the experimental process, HA ICC’s produced from aged and not aged gels were 
compared: 
 ICC’s produced from non-aged gels  
The resulting ICC’s were very brittle. Probably, the gel had no time to properly form a 
cohesive three dimensional network. 
 ICC’s produced from aged gels 
By the end of the aging process (24 hours at ambient temperature), 
the gel had a substantially higher viscosity (the gel agitation time 
was adjusted so to maintain a viscosity suitable for CC’s infiltration). 
Aging the gel before drying and sintering helped to strengthen the 
network and as a result the final product had higher structural 
integrity. This step was included in the production process of HA 
ICC’s, since it significantly improved the mechanical performance of 
the end product. 
4.2.3. Binders 
The HA/binder weight ratio was varied between 95:5, 97:3 and 98:2. Solution viscosity 
increased with higher amounts of binder. Since the microstructural differences were not 
significant, it was chosen to use the least amount of binder.   
Without the addition of a binder the resultant structure was very brittle becoming hard to handle 
without breaking. The absence of binder resulted in ICC walls with a large amount of surface 
defects, from which cracks would originate and propagate (Figure 4.5). Consequently, they 
presented poor mechanical strength.  
Figure 4.4 - Aspect 
of HA gel aged for 
24h after 5h stirring. 
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Figure 4.5- SEM image of HA ICC without binder. 
 
The binder was used to hold together the ceramic structure after HA gel drying. Two binders 
were tested - PVP and PVAc. The introduction of a binder reduced the amount of surface 
defects on ICC walls. Still, some minimal defects remained. Both binders allowed the production 
of a more consistent ICC with the desired geometry (when compared with an ICC with no 
binder). 
A better evaluation between the binders was made through comparison of ICC’s mechanical 
tests results and SEM micrographs. Their influence is better described in the chapters 4.3.1 and 
4.3.4.  
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4.3. ICC 
4.3.1. Thermal treatment and ICC structure 
A thermal treatment composed by multiple stages was used to turn a CC into an ICC (a stage 
stands for a time period in which a certain temperature was held). The used stages are 
described below.  
In the first attempts Stage 3 wasn’t included in the thermal treatment and the sintering 
temperature was equal or below 800ºC. Several problems remained cycle after cycle, so the 
sintering temperature was increased to 1100ºC and Stage 3 was added to the heating schedule.  
The following Stages constitute the final thermal treatment used for HA ICC’s production: 
 Stage 1: 75ºC - 20h (heating rate: 1ºC/min) 
At the first hold temperature there is the loss of the solvent and physically adsorbed water - 
this is the gel drying stage. It was held for a long time period to ensure complete solvent 
loss. The heat-up rate from ambient temperature was slow to prevent bloating from 
evaporation that could originate cracks in the structure. At this stage the CC’s were able to 
maintain its solid structure as the HA gel mixture dried. 
 Stage 2: 450ºC - 2h (heating rate: 2ºC/min) 
The next stage is much above PS glass transition temperature (§ 4.1.1.3), so the CC’s begin 
to soften during the heating phase. From this point on, the PS is gradually being degraded.   
The binders that are used for body strength when the HA gel is dry must be burned out 
before sintering because they would decompose in an uncontrolled manner at sintering 
temperatures, releasing a large amount of gas at high pressure that would cause the 
structure to crack. Also, the ICC shape could be lost.  
As the heating phase is taking place, PVP reaches its fusion temperature (~ 142 ºC) and at 
the plateau temperature the polymer loss approximately 91 % of its mass (Appendix B.1).  
During this stage, PVAc is above its glass transition and had a mass loss of 71% (Appendix 
B.2). 
Above 250ºC, pyrolysis of the dried gel molecular network begins. Pyrolysis creates tiny 
“holes” in the skeletal network that contribute to the pore volume and significantly increase 
the surface area because there is no associated shrinkage. The volatilization of the 
decomposition products of ligand groups is responsible for a weight loss [49], [50]. At the 
hold temperature the pyrolysis of organics is complete and HA crystallization begins.  
Due to all these events, a low heating rate was kept to ensure that ICC’s internal shape was 
not destroyed. 
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 Stage 3: 550ºC - 2h (heating rate: 2ºC/min) 
This step ensured polystyrene template’s complete degradation. All the definitive cavities in 
the ICC structure were created.  
By this stage PVP have undergone thermal decomposition and burned out. After binder 
burnout, the ICC is a porous structure composed by an assembly of ceramic particles. At this 
stage, PVAc is still suffering thermal degradation. 
Further HA crystallization may have occurred. 
 Stage 4: 600ºC, 800ºC, 1100ºC - 2h (heating rate: 10ºC/min) 
The last stage of the thermal treatment was for sintering, during which the majority of the 
densification and microstructure development took place. During the heat-up phase 
densification and microstructural changes may also have occurred.  
The temperatures mentioned above for this stage were attempted in order to produce a 
cohesive HA ICC. 
At the lower temperatures (600 and 800ºC) the densification was not effective. Coarsening of 
the ICC’s walls microstructure led to the formation of voids (Figure 4.6). When coarsening 
happens, the density does not increase even though the pores change shape. Thus, the 
particles were very loose and the structure was crumbly. The ICC walls exhibited 
microporosity and some roughness on the surface. 
 
Figure 4.6 - Microstructure of HA ICC wall (with PVP as binder) sintered at 600
o
C.  
 
If the interparticle separation distance remains the same, coarsening takes place. If the 
interparticle separation distance decreases, sintering takes place. Only sintering leads to an 
increase in density, which is referred to as densification (Figure 4.7) [49].  
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Figure 4.7 - The differences between coarsening and sintering [49]. 
 
The previous event is only valid at both sintering temperatures for ICC’s produced with PVP 
as a binder. At 600
o
C, PVAc isn’t fully degraded so these events were not observed. Since 
it’s a thermoplastic polymer, the remaining binder returned to solid state upon cooling which 
resulted in ICC with smoother walls. At 1100
o
C this binder has burned out.    
 
Figure 4.8 - Microstructure of HA ICC wall (with PVAc as binder) sintered at 600
o
C. 
At the higher temperature (1100ºC) densification took place (although incomplete) as 
confirmed by the shrinkage observed in the ICC’s after sintering. The final structure was 
much more stable than of those sintered at lower temperatures. The number of voids in 
ICC’s walls microstructure was reduced by the neck growth of the constituent grains (Figure 
4.9).  
The final ICC wall’s microstructure was affected by the used binder. Both “types” of ICC’s 
presented pores within the ceramic matrix since they were unable to complete densification.  
ICC’s walls with PVP as binder presented a higher amount of microporosity when compared 
with ICC’s made with PVAc. This could have been a result of the coarsening events that 
happened at the early stage of thermal treatment.  
Sintering at a higher temperature should be enough to achieve the final stage of sintering, 
coarsening 
densification 
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Figure 4.9 - SEM images of ICC’s sintered at 1100
o
C: (A) pores and (B) wall of ICC’s produced with 
PVAc as a binder; (C) pore and (D) wall of ICC produced with PVP as a binder. 
The HA ICC’s sintered at 1100ºC turned white while the sintered below turned dark (Figure 
4.10). It’s believed that above 800ºC, the residual organic groups were removed by 
decarbonation. Carbon is difficult to remove completely and the presence of carbon and other 
chemical residues in the final piece is normal [49]. 
   
Figure 4.10 - HA ICC's sintered (A) at 800 ºC and (B) at 1100 ºC. 
 
After sinterization, the HA ICC’s were cooled down to room temperature and removed from the 
muffle oven.  
A B 
D 
A B 
C D 
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The resulting ICC’s sintered at 1100
o
C exhibited an interconnected structure with 80 vol.% 
porosity. The internal architecture was conserved from the sacrificial template with average pore 
sizes of (200 ± 2) m (Figure 4.11). 
 
Figure 4.11 - SEM image of ICC scaffold sintered at 1100
o
C. 
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4.3.2. XRD Analysis  
The diffractograms of HA ICC’s sintered at 600°C, 800°C and 1100°C are shown in Figure 4.12. 
The XRD patterns were compared with JCPDS cards.   
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Figure 4.12 - Diffractograms of HA ICC’s sintered at 600°C, 800°C and 1100°C. 
 
Sintering temperature plays an important role on the formation of hydroxyapatite. As the 
sintering temperature is increased from 600
o
C to 1100
o
C, several of the HA peaks become 
more distinct and narrower which suggests an increase in the crystallinity degree (Figure 4.12). 
This affirmation is confirmed in Table 4.2, in which are presented the corresponding crystallite 
sizes determined by the Scherrer's formula (equation 1) and the crystallinity degree determined 
by equation 2.  
Table 4.2 - HA crystallite sizes for sintering temperatures of 600°C, 800°C and 1100°C. 
Sintering Temperature (ºC) Crystallite Size (𝒏𝒎) Crystallinity Degree (%) 
600ºC 25 ± 3 71 
800ºC 47 ± 5 78 
1100ºC 62 ± 3 98 
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(3) 
The stoichiometry of HA is highly significant when is required thermal processing of the material. 
Using stoichiometric hydroxyapatite it should be possible to sinter, without phase purity 
problems, at temperatures up to 1300
o
C [1]. However, a minor misbalance in the 
calcium/phosphorus ratio (from the standard molar ratio of 1.67) can lead to the appearance of 
additional crystalline phases during heat treatment. 
It can be seen that β-TCP (β-Ca3(PO4)2) appeared at all the sintering temperatures. Also, as the 
temperature rises to 1100°C, a fraction of β-TCP phase is transformed in α-tricalcium phosphate 
(α-TCP – α-Ca3(PO4)2). The CaO phase was observed after sintering at 800
o
C.  
These data indicates that HA can be decomposed into β-TCP/α-TCP and CaO as the sintering 
temperature is increased. The reaction is proposed as follows [51]: 
Ca10(PO4)6(OH)2    3Ca3(PO4)2  + CaO + H2O 
These calcium phosphates have different solubilities in vivo, being HA the least soluble [1]. A 
biphasic composition will influence the scaffold dissolution/bioresorption rate. Also, the 
scaffold’s microporous structure has an important role in this case due to the exhibited large 
surface area.  
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4.3.3. FTIR Analysis  
The most characteristic chemical groups in an HA FTIR spectra are PO4
3 -
, OH- and CO3
2 -
. The 
FTIR spectra of HA ICC’s sintered at different temperatures is shown in Figure 4.13.  
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Figure 4.13 - FTIR spectra of HA ICC’s sintered at 600°C, 800°C and 1100°C. 
The first indication of the formation of HA is in the form of broad band centered at about 1000 –
1100 cm−
1
. The bands at 960 – 965 cm−
1 
and at 560 – 601 cm−
1 
correspond to the symmetric P-
O stretching vibration of the PO4
3 -
 ion [52].  
CO3
2 -
 group forms a weak peak at 877 cm
-1
 and a wider band between 1459 and 1546 cm
-1 
that 
suggest the presence of a type A carbonated hydroxyapatite (hydroxyl ions are replaced with 
carbonate ions) [53].  
The bands assigned to the stretching modes of hydroxyl groups in the HA (3571 cm−
1
 and 632 
cm−
1
) can also be observed in the spectra [54].  
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4.3.4. Mechanical Properties 
The compressive strength of ceramic porous scaffolds depends on various factors. Both the 
macrostructure (the arrangement of pores) and the microstructure (for instance, the presence of 
cracks within the structure walls), have a strong influence on the mechanical behavior of the 
ceramic porous material. 
When a foam-like porous structure is compressed, the stress-strain curve usually shows three 
regions. At low stresses it shows linear elasticity followed by a long collapse plateau, ending 
with densification region in which the stress rises abruptly (Figure 4.14). 
 
Figure 4.14 - Schematic compressive stress-strain curve for an elastic-brittle 
foam, showing the three regimes of linear elasticity, collapse and densification                 
           (Adapted from [55]). 𝛔𝐜𝐫
 ∗  - crushing stress; ∈𝐃 - densification strain. 
 
On first compressive loading, the cell walls bend; the material exhibits a pseudo elastic 
behavior. The Young’s modulus corresponds to the initial slope of the stress-strain curve in this 
region. When a critical stress (σcr
 ∗  - crushing stress) is reached the cells begin to collapse 
continuously by brittle fracture/crushing of their walls. This collapse will proceed under constant 
load to a relatively high strain level. Eventually, at high strains, the cells collapse sufficiently that 
opposing cell walls touch (or their broken fragments pack together) and further deformation 
compresses the cell wall material itself. This gives the final region of rapidly increasing stress 
labelled densification [55]. 
Figure 4.15 shows that the obtained stress-strain curves for the HA ICC’s are similar to the 
standard curve for brittle porous materials characterized by three distinct regions, although the 
elastic region is very small. 
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It can be seen that the mechanical strength of HA ICC’s to compression increases with the 
sintering temperature (Table 4.3). These results are in agreement with that exposed in chapter 
4.3.1.  
In Figure 4.15 and Table 4.3 are only presented the results for scaffolds produced with PVAc as 
a binder, since they showed better mechanical properties. For the scaffolds made with PVP the 
results for 600ºC and 800ºC were similar to the ones in the table below. In this case, the ICC’s 
sintered at 1100ºC exhibited a Young modulus of (398 ± 125) KPa. 
Table 4.3 - Mechanical properties of HA ICC's sintered at 600
o
C, 800
o
C and 1100
o
C. 
ICC [named after sintering temperature] Young Modulus (KPa) 
600ºC 171 ± 12 
800ºC 227 ± 34 
1100ºC   747 ± 130 
 
 
  
Figure 4.15 - Compressive stress-strain curves for HA ICC’s sintered at 600
o
C, 800
o
C and 1100
o
C. 
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4.3.5. Biocompatibility Evaluation  
In vitro tests demonstrated the nontoxic nature of the produced HA ICC scaffolds.  
On the first day after seeding the cells showed 47% of adhesion to the ICC surface. The 
adhesion of osteoblast cells onto the ICC surface is a necessary step before cells proliferate 
and differentiate further. Throughout the 10 days of culture it was observed an increase in the 
resazurin test absorbance values meaning a proportional increase of the number of cells 
(Figure 4.16). This shows that the samples were able to promote cellular proliferation.  
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Figure 4.16 - Corrected absorbance over an incubation period of 10 days 
 
Fluorescence microscopy confirmed that human osteoblasts were able to attach, proliferate and 
inhabit the scaffolds. The abundance of stained cells (the bright spots correspond to the cell’s 
nucleus) indicates a good viability (Figure 4.17). The seeded cells coated the ICC’s outer 
surface and appear to have infiltrated within the scaffold, yielding a uniform population 
throughout the structure. 
 
Figure 4.17 - Fluorescence microscopy image of human osteoblasts (Saos-2 cell line) 
on HA ICC taken after 10 days of culture. The bright spots correspond to the cells on the 
ICC’s outer surface; the diffuse round spots correspond to the cells within the scaffold. 
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It was not possible to visualize the seeded osteoblasts through SEM. Instead, a layer of needle-
like crystals over the ICC surface was revealed. The cauliflower morphology resulting from the 
assembling of these structures suggests them to be calcium phosphates (Figure 4.18). 
Biomineralization may have occurred on top of the attached cells as a consequence of calcium 
and phosphate ions release possibly resulting from HA dissolution and calcium secretion by 
cells. This reveals the bioactive nature of the produced scaffolds. 
  
 
Figure 4.18 - SEM micrographs of ICC surface revealing the deposited layer of needle-like crystals 
with cauliflower morphology: (A) Pore and wall; (B) magnification of cauliflower structures. 
 
  
A 
B 
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5. Conclusions and Future Perspectives  
Porous scaffolds with ICC geometry for application in bone tissue engineering were produced 
and characterized. The resulting scaffolds presented a biphasic composition of HA/β-TCP with 
macropore sizes of 200 m in diameter and a porosity of about 80 vol.%. 
Templates with an hcp structure of polystyrene microspheres (270 m) were prepared by self- 
assembling and necking by heating at 130
o
C for 4 hours. It was verified that the necks between 
particles and future ICC windows could be easily tuned by changing the annealing time and 
temperature.  
The scaffold material was prepared via a simple sol–gel method. It was found that a gel with 
suitable viscosity for colloidal crystal impregnation could be achieved after 5 hour stirring at 
ambient temperature. An aging time of 24 hours was added to strengthen the gel’s three-
dimensional network.     
The resulting HA gel was mixed with two different binders: PVP and PVAc. Their influence was 
compared after ICC sintering through mechanical testing and microstructure evaluation. PVAc 
allowed a better mechanical performance. 
The HA gel was vacuum infiltrated into the particle-assembled template, followed by a heat 
treatment to burn out the polymer microspheres and sinter the HA. A range of sintering 
temperatures was tested (600-1100
o
C). It was verified that sintering at 800
o
C or below was not 
effective in promoting densification. Sintering at 1100
o
C was required for the ceramic particles 
to join and form a more continuous structure.  
The fabricated scaffold showed an ordered pore structure that negatively replicated the 
microspheres and their necks in the colloidal crystal template. However, the interconnectivity 
between pores was not completely uniform throughout the scaffold. This could possibly be 
improved by using highly monosized microspheres which would allow even necking during CC 
production.  
The scaffolds exhibited high crystallinity which increased with increasing of sintering 
temperature (71-98%). FTIR analysis revealed the presence of a type A HA. 
The HA ICC’s sintered at 1100
o
C demonstrated the best results in terms of mechanical 
properties. Nevertheless, they showed a low compressive strength around 747 kPa. This could 
be mainly due to incomplete densification of ICC walls that probably would be solved with 
increasing of the sintering temperature. Another possible reason is the existence of gaps in the 
scaffold material due to irregular infiltration of HA gel into the colloidal crystal. 
In vitro biocompatibility with human osteoblasts was demonstrated. The cells were able to 
attach and proliferate. Also, it was revealed an apatite forming ability with the appearance of 
needle-like cauliflower structures. Therefore it is expected that the scaffolds can provide a 
favorable environment for bone ingrowth.  
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The objectives of this work were partially achieved: a hydroxyapatite porous scaffold with 
inverse colloidal crystal geometry was produced but further work is needed to refine its 
mechanical properties (which are low when compared with commercially available HA 
scaffolds). 
In the future several developments can be made to improve the HA ICC’s and the developed 
production method: 
 Sintering at an higher temperature (example, 1300
o
C) to improve the scaffold´s mechanical 
properties by enabling complete densification;  
 Optimize the thermal treatment for ICC production in order to reduce production time (and 
inherent costs) while preserving ICC structural integrity; 
 Study the sol gel system to explore the effect of gel agitation and aging time over the 
scaffold’s microstructure and to optimize the gel viscosity for CC impregnation; 
 Further in vitro testing to evaluate the scaffolds solubility, behavior in biological environment 
and the possible existence of calcium secretion by cells; 
 Integrate solid freeform fabrication based techniques with the ICC structures to create a 
more ordered, precise and controllable architecture. 
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APPENDIX A 
Cytotoxicity Tests 
A proper aseptic technique was used throughout all the experimental procedures. All the steps 
were carried out in a laminar flow hood (ESCO Labculture II) when required. 
A.1.   ICC’s preparation for cell culture 
1. ICC’s sterilization: The samples were placed in ethanol. 
2. After ethanol removal, the samples were washed with PBS. 
3. The culture medium was added to the samples. 
A.2.   Thawing of cells 
1. Frozen osteoblasts from Saos-2 cell line were thawed rapidly in a 37
o
C water bath. The vial 
was gently swirled in water bath until there was just a small bit of ice left. 
2. The vial was transferred into the laminar flow hood. Pre-warmed culture medium (solution of 
McCoy’s 5A Medium (Sigma-Aldrich) supplemented with 10% of Fetal Bovine Serum 
(Gibco®) and 1% of Penicillin-Streptomycin (Gibco®)) was added to the thawed cells in a 
conical tube. The tube was centrifuged for 5 minutes at 150g to promote formation of a cell 
pellet so it was possible to remove the DMSO (> 99.9%, Merk) contained in the freezing 
media. 
3. The supernatant was decanted. The cells were resuspended in new culture medium. 
4. The cell suspension was transferred to a cell culture flask and placed in a CO2 incubator at 
37
o
C (Sanyo CO2 incubator). 
A.3.   Subculturing of cells 
1. The cell culture medium was removed from the cell culture flask where the cells had been 
previously placed.  
2. The cells were washed with PBS and the wash solution was removed from the culture flask. 
3. Pre-warmed trypsin enzyme (TrypLETM Gibco) was added to the cells and the container was 
placed in the CO2 incubator at 37
o
C for 5 minutes. 
4. The cells were observed under the microscope (Nikon Inverted Microscope Eclipse Ti-S) to 
ensure its detachment. 
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5. Pre-warmed culture medium was added to the cells and the suspension was transferred to a 
conical tube.  
6. The number of cells was determined using a hemocytometer:  
6.1. A sample of the suspension prepared in 5 was transferred to an Eppendorf tube and 
mixed with the same amount of Trypan Blue (dilution factor of 2). 
6.2. The hemocytometer was loaded with the mixture and examined under the microscope 
at low magnification. 
6.3. The number of bright cells was counted. 
A.4.   Measuring Citotoxicity  
1. The ICC’s were placed in a multi well plate. 
2. A mixture of cell suspension and culture medium was made. 
3. The ICC’s were placed in a multi well plate. Four different “types of wells” were prepared:  
 Medium Control well: containing medium without cells; 
 ICC Medium Control well: containing ICC’s and medium without cells; 
 Cell Control well: containing medium with cells; 
 Test well: containing ICC’s and medium with cells.  
Cells were seeded in the last two types of wells at a concentration of 30 000 cells/well 
4. The multi well plate was incubated at 37
o
C for 20 hours to allow the cells to adhere. 
5. The ICC’s in the Test wells were transferred to empty wells.  
6. The culture medium was removed from the wells and in its place was added a 10% V/V 
solution of resazurin (0.2 mg/mL) and culture medium. 
7. After incubation for 2 hours the solution contained in the wells was transferred to a 96 well 
microplate. 
8. The fluid absorbance was read at 570 and 600 nm in a microplate reader (Biotek ELx 800). 
The reading was performed in quadruplicates.  
9. The remaining resazurin solution was removed from the multi well plate. 
10. The samples were washed with PBS and fresh culture medium was added to the cultures. 
11. Steps 6 to 10 were repeated for 10 days on days 3, 6, 8 and 10. 
A.5.   Cell Fixation and Staining  
1. The cell culture medium was removed from the multi well plate and the samples were 
washed with PBS. 
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2. A 3.7% paraformaldehyde solution was added to the samples in order to fix the cells. 
3. After incubation at room temperature for 10 min, the samples were washed with PBS. 
4. The samples were stained with DAPI and incubated for 5 minutes at room temperature. 
5. The samples were rinsed in PBS. 
6. The samples were observed through fluorescence microscopy. 
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APPENDIX B 
Binders TG-DSC 
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Figure B.1 - TG-DSC thermogram for PVP 
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Figure B.2 - TG-DSC thermogram for PVAc 
 
44 
 
 
 
